Comparative efficacy and safety of amorolfine nail lacquer 2% versus 5% once weekly

Journal Article Comparative efficacy and safety of amorolfine nail lacquer 2% versus 5% once weekly Get access J. LAUHARANTA J. LAUHARANTA Department of Dermatology, Helsinki University Central Hospital, Finland Dr J. Lauharanta, Department of Dermatology, Helsinki University Central Hospital, Meilahdentie 2, SF‐00250 Helsinki, Finland. Search for other works by this author on: Oxford Academic Google Scholar Clinical and Experimental Dermatology, Volume 17, Issue s1, 1 September 1992, Pages 41–43, https://doi.org/10.1111/j.1365-2230.1992.tb00277.x Published: 01 September 1992